NOVACYT, founded in 2006, by an experimented team coming from biotech and industrial companies, is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. • NOVACYT has been recognized as a highly innovative company by GENOPOLE and OSEO, through a dedicated patent strategy and complete portfolio of patents. • The Company is headquartered in Vélizy-Villacoublay (France), where it also operates its development, marketing, sales and operations. • Initially purely focused on the development of fully automated solution for liquid based cytology, the company has been backed by venture capitalists to develop highly innovative projects (innovative equipment and related reagents based for imaging analysis) and commercial presence worldwide since 2009. • NOVACYT now positions itself as the specialist and market leader in fully automated liquid based cytology for cancer screening with improvement for laboratories workflow and throughput: multipurpose platform allowing GYN cytology, NON GYN cytology, multi slide preparation, pre-aliquoting for reflex testing by molecular biology... • Our flagships products, related to a proprietary range of innovative equipment and devices for liquid based cytology, increase laboratory efficiency.
Looking for a particular NOVACYT employee's phone or email?
NOVACYT Questions
The NOVACYT annual revenue was $14.7 million in 2026.
Martin Shaw is the Sales Director of NOVACYT.
4 people are employed at NOVACYT.
NOVACYT is based in Velizy-Villacoublay, Ile-de-France.
The NAICS codes for NOVACYT are [3254, 325413, 32, 325, 32541].
The SIC codes for NOVACYT are [28, 283].
Top NOVACYT Employees
-
Martin Shaw
Sales Director at NOVACYT
Dorchester, GB1 -
2
-
Luc Nubel
INTERNATIONAL PRODUCT MANAGER at NOVACYT
Sury-en-Vaux, FR2
